SGEN Stock Summary

• With a market capitalization of $18,278,280,212, Seattle Genetics Inc has a greater market value than 89.69% of US stocks.
• SGEN's price/sales ratio is 22.81; that's higher than the P/S ratio of 94.49% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.2 for Seattle Genetics Inc; that's greater than it is for only 11.42% of US stocks.
• If you're looking for stocks that are quantitatively similar to Seattle Genetics Inc, a group of peers worth examining would be SWKS, STX, HALO, XLNX, and BLUE.
• Visit SGEN's SEC page to see the company's official filings. To visit the company's web site, go to www.seattlegenetics.com.